Advances and counterpoints in type 2 diabetes. What is ready for translation into real-world practice, ahead of the guidelines-Reference-Cited by-同舟云学术

Advances and counterpoints in type 2 diabetes. What is ready for translation into real-world practice, ahead of the guidelines

Published:2024-09-04 Issue:1 Volume:22 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Schwartz Stanley S.,Corkey Barbara E.,R Gavin James,DeFronzo Ralph A.,Herman Mary E.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12916-024-03518-5.pdf

Reference127 articles.

1. Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, et al. Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel. Diabetes. 2020;69(10):2037–47.

2. American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care. 2009;32(Supplement_1):S13-61. Available from: https://diabetesjournals.org/care/article/32/Supplement_1/S13/25055/Standards-of-Medical-Care-in-Diabetes-2009.

3. Henry RR, Murray A V., Marmolejo MH, Hennicken D, Ptaszynska A, List JF. Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial. Int J Clin Pract. 2012;66(5):446–56. Available from: https://www.onlinelibrary.wiley.com/doi/10.1111/j.1742-1241.2012.02911.x.

4. Khunti K, Ceriello A, Cos X, De Block C. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract. 2018;137:137–48. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168822717314468.

5. Unger J, Schwartz Z. Introduction to diabetes. In: Diabetes management in primary care- second edition. 2nd ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2012. p. 1–37.